Rollover Study From EXG-US-01
NCT05868499
·
clinicaltrials.gov ↗
PHASE1
Phase
ENROLLING_BY_INVITATION
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Telomere Biology Disorders With Bone Marrow Failure
Interventions
BIOLOGICAL:
EXG34217
Sponsor
Elixirgen Therapeutics, Inc.